Bebetter Med Inc

This Phase 3 trial is testing whether the experimental drug BEBT-908, when combined with rituximab, can improve survival in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Participants will be randomly assigned to receive either this new combination or a…

This early-stage trial is testing an investigational drug called BEBT-507 in adults with polycythemia vera, a condition where the body makes too many red blood cells. The study aims to find a safe dose and see if the drug can help control blood cell levels, potentially reducing t…

This trial is testing whether an experimental drug called BEBT-109, taken as a pill, can safely and effectively work alongside standard chemotherapy to treat a specific type of non-small cell lung cancer that has a particular genetic change (EGFR exon 20 insertion). The study inv…

This study tests a new medicine called BEBT-701, given as a shot under the skin, for people with mild to moderate high blood pressure and high LDL cholesterol. The goal is to see if it is safe and can help lower both blood pressure and cholesterol. About 340 adults aged 18 to 60 …

This study tests whether adding a new drug called BEBT-209 to standard chemotherapy can shrink tumors and help people with advanced triple-negative breast cancer live longer. About 446 women aged 18 to 75 will be randomly assigned to receive either BEBT-209 plus two chemo drugs o…